Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at editorial@medicaldialogues.in.

Home

sheeba farhat

Articles By : sheeba farhat

Eli Lilly to Invest USD 3 Billion in China to Boost Production of Diabetes, Obesity Drug Orforglipron

sheeba farhat12 March 2026 10:00 AM IST

Shanghai: Eli Lilly plans to invest USD 3 billion over the next decade to expand supply chain capacity in China and build production capacity for its...

USFDA Expands Use of GSKs RSV Vaccine Arexvy to Adults 18-49 at Risk

GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to USD 690 Million

sheeba farhat10 March 2026 11:03 PM IST

Bengaluru: GSK said on Monday it will receive up to USD 690 million from Italian ‌pharmaceutical ⁠company Alfasigma for ⁠the worldwide rights to...

Roche Breast Cancer Drug Giredestrant Fails Late-Stage Trial Goal

sheeba farhat10 March 2026 10:56 PM IST

Frankfurt: Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising breast cancer drug candidate...

USFDA Launches AEMS Platform to Track Drug, Vaccine Adverse Events in Real Time

USFDA May Relax Biosimilar Testing Requirements, Development Costs Could Drop by USD 20 Million

sheeba farhat10 March 2026 10:41 PM IST

Bengaluru: The U.S. Food and Drug Administration plans to ease testing requirements for companies developing biosimilar drugs, Bloomberg News...

Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing Issue

sheeba farhat9 March 2026 7:16 PM IST

New Delhi: A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue,...

Japan Approves World's First Stem-Cell Therapies for Parkinson's and Heart Failure

sheeba farhat9 March 2026 7:06 PM IST

Tokyo: Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports...

Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management

sheeba farhat8 March 2026 11:30 AM IST

Shanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...

Servier to Buy Day One Biopharma for USD 2.5B, Adds USFDA-Approved Brain Tumor Drug Ojemda

sheeba farhat8 March 2026 11:00 AM IST

Bengaluru: French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals for about USD 2.5 billion, expanding its brain...

Tresiba, Toujeo, Humalog Among Insulin Stocks Seized in Delhi Raid, 2 Firms Booked

sheeba farhat7 March 2026 8:07 PM IST

A total of 2,104 units of insulin preparations worth Rs 20,06,024 were seized during the drive.

USFDA Biologics Chief Vinay Prasad to Exit in April Amid Regulatory Controversies

sheeba farhat7 March 2026 7:55 PM IST

New York: The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr Vinay Prasad, will leave the agency at...

Indian Pharma Faces Rs 5,000 Crore Export Risk as Middle East Conflict Drives Freight Charges Up

sheeba farhat6 March 2026 11:01 PM IST

New Delhi: The domestic pharma industry is staring at a loss ranging between Rs 2,500 crore and Rs 5,000 crore due to the various supply and freight...

USFDA Approves Johnson and Johnson Blood Cancer Drug Tecvayli-Darzalex Combo

USFDA Approves Johnson and Johnson's Blood Cancer Drug Tecvayli-Darzalex Combo via Fast-Track Voucher Program

sheeba farhat6 March 2026 10:52 PM IST

Bengaluru: The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making ‌it the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok